These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8572465)
41. A seeming failure of logic. Ackerman AB Arch Dermatol; 2006 Feb; 142(2):244-5; author reply 245. PubMed ID: 16490858 [No Abstract] [Full Text] [Related]
42. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes. Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078 [TBL] [Abstract][Full Text] [Related]
43. Massive nodular melanoma: a case report. Harting M; Tarrant W; Kovitz CA; Rosen T; Harting MT; Souchon E Dermatol Online J; 2007 May; 13(2):7. PubMed ID: 17498426 [TBL] [Abstract][Full Text] [Related]
44. [When, how and which patients should be screened for second melanoma?]. Dreno B Ann Dermatol Venereol; 1995; 122(5):310-4. PubMed ID: 8572472 [No Abstract] [Full Text] [Related]
45. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. Kuo CT; Hoon DS; Takeuchi H; Turner R; Wang HJ; Morton DL; Taback B J Clin Oncol; 2003 Oct; 21(19):3566-72. PubMed ID: 12913098 [TBL] [Abstract][Full Text] [Related]
46. [Tests for the assessment of the extensiveness of malignant melanoma]. Proust S Soins Chir; 1984; (42-43):7-8. PubMed ID: 6569633 [No Abstract] [Full Text] [Related]
51. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909 [TBL] [Abstract][Full Text] [Related]
52. Consumption of the epidermis--what is its place in the spectrum of aberrant melanocyte-keratinocyte interactions? Cramer SF Am J Dermatopathol; 2008 Apr; 30(2):200-3. PubMed ID: 18360135 [No Abstract] [Full Text] [Related]
53. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604 [TBL] [Abstract][Full Text] [Related]
54. Mythology and numerology in the sphere of melanoma. Ackerman AB Cancer; 2000 Feb; 88(3):491-6. PubMed ID: 10649238 [No Abstract] [Full Text] [Related]
55. Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma. Moehrle M; Kraemer A; Schippert W; Garbe C; Rassner G; Breuninger H Br J Dermatol; 2004 Aug; 151(2):397-406. PubMed ID: 15327547 [TBL] [Abstract][Full Text] [Related]
56. Melanoma prognostic factors found in the dermatopathology report. Payette MJ; Katz M; Grant-Kels JM Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154 [TBL] [Abstract][Full Text] [Related]
57. Cutaneous melanoma: detecting it earlier, weighing management options. Lane JE; Dalton RR; Sangueza OP J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894 [No Abstract] [Full Text] [Related]
58. Diffuse cutaneous melanosis in malignant melanoma. Paulo Filho Tde A; da Trindade Neto PB; Reis JC; Bartelt L; da Costa SA Dermatol Online J; 2007 May; 13(2):9. PubMed ID: 17498428 [No Abstract] [Full Text] [Related]
59. The accuracy of dermatologists in the diagnosis of melanoma. Berry TN Arch Dermatol; 1992 Sep; 128(9):1278. PubMed ID: 1519949 [No Abstract] [Full Text] [Related]